NO874032L - Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.

Info

Publication number: NO874032L
Authority: NO; Norway
Prior art keywords: catechold; derivatives; procedure; preparation; therapeutic active
Prior art date: 1986-09-26

Application number

NO874032A

Other languages

English (en)

Other versions

NO874032D0 (no

Inventor

Shigenobu Nakayama

Fumiaki Ikeda

Original Assignee

Mitsui Toatsu Chemicals

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-09-26

Filing date

1987-09-25

Publication date

1988-03-28

1986-09-26 Priority claimed from JP61226135A external-priority patent/JPS6383020A/ja

1986-12-22 Priority claimed from JP61303761A external-priority patent/JPS63156751A/ja

1987-02-20 Priority claimed from JP62035697A external-priority patent/JPS63203678A/ja

1987-05-27 Priority claimed from JP62128444A external-priority patent/JPS63295571A/ja

1987-09-25 Application filed by Mitsui Toatsu Chemicals filed Critical Mitsui Toatsu Chemicals

1987-09-25 Publication of NO874032D0 publication Critical patent/NO874032D0/no

1988-03-28 Publication of NO874032L publication Critical patent/NO874032L/no

1992-04-13 Priority to NO921475A priority Critical patent/NO921475D0/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Emergency Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO874032A 1986-09-26 1987-09-25 Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. NO874032L (no)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO921475A NO921475D0 (no)	1986-09-26	1992-04-13	Analogifremgangsmaate for fremstilling av terapeutisk aktive catecholderivater

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP61226135A JPS6383020A (ja)	1986-09-26	1986-09-26	中枢性神経退行性疾患の進行防止および治療剤
JP61303761A JPS63156751A (ja)	1986-12-22	1986-12-22	カテコール誘導体の製造方法
JP62035697A JPS63203678A (ja)	1987-02-20	1987-02-20	新規なカテコール誘導体
JP62128444A JPS63295571A (ja)	1987-05-27	1987-05-27	カテコ−ル誘導体

Publications (2)

Publication Number	Publication Date
NO874032D0 NO874032D0 (no)	1987-09-25
NO874032L true NO874032L (no)	1988-03-28

Family

ID=27460132

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO874032A NO874032L (no)	1986-09-26	1987-09-25	Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.

Country Status (9)

Country	Link
US (2)	US4985458A (no)
EP (1)	EP0261977B1 (no)
KR (1)	KR900001511B1 (no)
AU (1)	AU603137B2 (no)
DE (1)	DE3777050D1 (no)
DK (1)	DK505787A (no)
FI (1)	FI874163A7 (no)
NO (1)	NO874032L (no)
NZ (1)	NZ221933A (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ228329A (en) *	1988-03-18	1991-12-23	Mitsui Toatsu Chemicals	Catechol derivatives and pharmaceutical compositions thereof
US5232923A (en) *	1988-03-18	1993-08-03	Mitsui Toatsu Chemicals, Incorporated	Catechol derivatives and pharmaceutical preparations containing same
PT94121A (pt) *	1989-05-23	1991-02-08	Sankyo Co	Processo para a preparacao de derivados fenol para promover o factor de crescimento do nervo humano
US5290793A (en) *	1989-09-12	1994-03-01	Mitsui Toatsu Chemicals, Incorporated	Dihydrocaffeic acid derivatives and pharmaceutical preparation containing same
JPH0660141B2 (ja) *	1989-09-12	1994-08-10	三井東圧化学株式会社	ジヒドロカフェイン酸誘導体およびそれを有効成分として含有する治療剤
US5677288A (en) *	1991-05-15	1997-10-14	Cypros Pharmaceutical Corporation	Use of aminoglycosides to protect against excitotoxic neuron damage
US5281607B1 (en) *	1992-10-08	1998-05-19	Univ New York	Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases
US6242468B1 (en)	1997-02-27	2001-06-05	Jia-He Li	Carbamate and urea compositions and neurotrophic uses
WO1999037294A2 (en)	1998-01-26	1999-07-29	Mitokor	Mitochondria protecting agents for treating mitochondria associated diseases
US5950896A (en) *	1998-02-09	1999-09-14	Theodore; Dean Anthony	Multi-purpose thoracic sac
KR100711537B1 (ko)	2000-01-27	2007-04-27	다카라 바이오 가부시키가이샤	치료제
JP2001233835A (ja) *	2000-02-28	2001-08-28	Nagase & Co Ltd	カルノジン酸誘導体およびそれを用いた神経成長因子合成促進剤
JP2005305107A (ja) *	2004-03-25	2005-11-04	Sei Matsuoka	価値的情報値の測定装置およびこれを使用した測定方法
FR2869033B1 (fr) *	2004-04-20	2006-06-02	Rhodia Chimie Sa	Procede de preparation de methylenedioxybenzene
CA2734991A1 (en) *	2008-07-23	2010-01-28	Massachusetts Institute Of Technology	Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
WO2010079423A1 (en) *	2009-01-12	2010-07-15	Council Of Scientific & Industrial Research	Inhibitors of phosphatidylinositol-3-kinase (pi3) and inducers of nitric oxide (no)
TR201901856T4 (tr)	2011-07-22	2019-03-21	Massachusetts Inst Technology	Sınıf I histon deasetilazların (HDAC'ler) aktivatörleri ve kullanımları.
US10253051B2 (en)	2015-03-16	2019-04-09	Lockheed Martin Energy, Llc	Preparation of titanium catecholate complexes in aqueous solution using titanium tetrachloride or titanium oxychloride
US10644342B2 (en)	2016-03-03	2020-05-05	Lockheed Martin Energy, Llc	Coordination complexes containing monosulfonated catecholate ligands and methods for producing the same
US10316047B2 (en)	2016-03-03	2019-06-11	Lockheed Martin Energy, Llc	Processes for forming coordination complexes containing monosulfonated catecholate ligands
US9938308B2 (en)	2016-04-07	2018-04-10	Lockheed Martin Energy, Llc	Coordination compounds having redox non-innocent ligands and flow batteries containing the same
US10377687B2 (en) *	2016-07-26	2019-08-13	Lockheed Martin Energy, Llc	Processes for forming titanium catechol complexes
US10343964B2 (en)	2016-07-26	2019-07-09	Lockheed Martin Energy, Llc	Processes for forming titanium catechol complexes
US10930937B2 (en)	2016-11-23	2021-02-23	Lockheed Martin Energy, Llc	Flow batteries incorporating active materials containing doubly bridged aromatic groups
US10497958B2 (en)	2016-12-14	2019-12-03	Lockheed Martin Energy, Llc	Coordinatively unsaturated titanium catecholate complexes and processes associated therewith

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE916208C (de) *	1951-06-05	1954-08-05	Pohl G	Verfahren zur Herstellung einer Loesung von Hexylresorcin, insbesondere fuer Arzneimittelzwecke
FR7131M (no) *	1968-01-31	1969-07-21
JPS4742760Y1 (no) *	1969-02-19	1972-12-25
US3631227A (en) *	1970-02-27	1971-12-28	Texaco Inc	Halocyclohexanone conversion to catechol diacetate
CA1004231A (en) *	1971-10-18	1977-01-25	Mahmoud S. Kablaoui	Halocyclohexanone conversion to catechol diacetate
DE2155985A1 (de) *	1971-11-11	1973-05-17	Texaco Development Corp	Verfahren zur herstellung von ggf. alkyliertem mono- oder diacetoxybenzol
IT1054578B (it) *	1976-01-30	1981-11-30	Brichima Spa	Processo per la preparazione di composti metilendiossiaro matici
US4608391A (en) *	1977-07-05	1986-08-26	Cornell Research Foundation Inc.	Catecholamine derivatives, a process for their preparation and pharmaceutical compositions thereof
DE2816190A1 (de) *	1978-04-14	1979-10-25	Bayer Ag	Neue benzodioxolderivate
US4241097A (en) *	1979-09-13	1980-12-23	International Flavors & Fragrances Inc.	Use of benzodionones in augmenting or enhancing the aroma and taste of a foodstuff
CA1175058A (en) *	1980-04-07	1984-09-25	James E. Lyons	Selective production of phenylene diacetate
DE3332955A1 (de) *	1983-09-13	1985-03-28	Merck Patent Gmbh, 6100 Darmstadt	Carbocyclische sechsringverbindungen
US4559328A (en) *	1984-06-21	1985-12-17	Warner-Lambert Company	Non-steroidal anti-inflammatory compounds to treat inflammation
DE3431222A1 (de) *	1984-08-24	1986-03-06	Bayer Ag, 5090 Leverkusen	Neue benzokondensierte, fluorierte, heterocyclische verbindungen, ein verfahren zu ihrer herstellung und ihre verwendung
TR22733A (tr) *	1984-12-14	1988-05-24	Clorox Co	Fenilen mono-ve diester perasit iptidai maddeler
US4761491A (en) *	1984-12-24	1988-08-02	The Dow Chemical Company	Preparation of 2-substituted-1,3-dioxacycloalkanes from diols and diunsaturated ethers
JPS61197541A (ja) *	1985-02-26	1986-09-01	Sanyo Kokusaku Pulp Co Ltd	新規なアクリレ−ト化合物およびその製造法
US4820366A (en) *	1987-03-06	1989-04-11	Phillips Petroleum Company	Apparatus and method for pultruding reinforced plastic articles
US4803290A (en) *	1987-05-29	1989-02-07	Pcri, Inc.	Nonanol/nonene antimicrobial compositions
JPH02249945A (ja) *	1989-03-24	1990-10-05	Hitachi Ltd	折り曲げ強度検査装置

1987
- 1987-09-23 FI FI874163A patent/FI874163A7/fi not_active Application Discontinuation
- 1987-09-25 NZ NZ221933A patent/NZ221933A/xx unknown
- 1987-09-25 NO NO874032A patent/NO874032L/no unknown
- 1987-09-25 DK DK505787A patent/DK505787A/da not_active Application Discontinuation
- 1987-09-25 EP EP87308482A patent/EP0261977B1/en not_active Expired - Lifetime
- 1987-09-25 DE DE8787308482T patent/DE3777050D1/de not_active Expired - Lifetime
- 1987-09-25 AU AU78956/87A patent/AU603137B2/en not_active Ceased
- 1987-09-25 KR KR1019870010738A patent/KR900001511B1/ko not_active Expired
1990
- 1990-02-20 US US07/481,677 patent/US4985458A/en not_active Expired - Fee Related
- 1990-10-31 US US07/606,817 patent/US5102906A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0261977A2 (en)	1988-03-30
US4985458A (en)	1991-01-15
KR880003622A (ko)	1988-05-28
AU7895687A (en)	1988-03-31
AU603137B2 (en)	1990-11-08
FI874163L (fi)	1988-03-27
NO874032D0 (no)	1987-09-25
EP0261977A3 (en)	1989-04-05
DK505787A (da)	1988-03-27
NZ221933A (en)	1989-09-27
DK505787D0 (da)	1987-09-25
KR900001511B1 (ko)	1990-03-12
US5102906A (en)	1992-04-07
FI874163A7 (fi)	1988-03-27
EP0261977B1 (en)	1992-03-04
DE3777050D1 (de)	1992-04-09
FI874163A0 (fi)	1987-09-23

Publication	Publication Date	Title
NO871266D0 (no)	1987-03-26	Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO883974D0 (no)	1988-09-07	Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO870526D0 (no)	1987-02-11	Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO864126D0 (no)	1986-10-16	Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO871267D0 (no)	1987-03-26	Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO894630L (no)	1990-05-23	Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO904694D0 (no)	1990-10-30	Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO870075L (no)	1987-07-09	Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO901684L (no)	1990-10-19	Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO874869D0 (no)	1987-11-23	Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO874032L (no)	1988-03-28	Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO874153D0 (no)	1987-10-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO871588D0 (no)	1987-04-14	Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO875488D0 (no)	1987-12-30	Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO871044D0 (no)	1987-03-13	Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO862372D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO891723D0 (no)	1989-04-26	Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO167802C (no)	1991-12-11	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO864101L (no)	1987-04-21	Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO900972L (no)	1990-09-04	Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO871907D0 (no)	1987-05-07	Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO874780D0 (no)	1987-11-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
NO900942D0 (no)	1990-02-28	Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO890724L (no)	1989-08-23	Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO166715C (no)	1991-08-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater.